Lucy Brady Acquires Shares in Bath & Body Works

Lucy Brady recently purchased 7,970 shares of Bath & Body Works, Inc. (NYSE:BBWI) on June 11, 2026. This insider transaction was not made under a prearranged trading plan and was executed at no cost, as the shares were acquired as part of a planned distribution.

Insider Buying and Selling at Bath & Body Works, Inc.

Several insiders at Bath & Body Works made similar moves around the same time. Javitch Tom, the Interim CFO, acquired 10,309 shares on June 12, 2026. On June 11, 2026, Alessandro Bogliolo, Juan Rajlin, Sarah Nash, and Francis Hondal each purchased 7,970 shares. These transactions were not part of any Rule 10b5-1 plans.

Other Institutional Activity in Bath & Body Works

In recent institutional activity, FMR LLC increased its holdings in Bath & Body Works by 3,944,735 shares, bringing its total to 20,888,799 shares valued at approximately $389.99 million. BlackRock, Inc. reduced its position by 1,826,464 shares, leaving it with 19,322,372 shares worth about $360.75 million. Vanguard Portfolio Management LLC added 15,021,767 shares, resulting in a total of 15,021,767 shares valued at $280.46 million. AQR Capital Management LLC trimmed its stake by 405,215 shares, now holding 11,040,713 shares worth $206.13 million. D. E. Shaw & Co., Inc. increased its investment by 3,735,358 shares, totaling 9,504,593 shares valued at $177.45 million.

Bath & Body Works Stock Snapshot

Shares of Bath & Body Works, Inc. (NYSE:BBWI) are trading around $19.40. The company boasts a market capitalization of approximately $3.91 billion and a P/E ratio of 5.51. The stock has seen a 52-week low of $14.28 and a high of $33.96. Its 50-day moving average stands at $18.64, while the 200-day moving average is $21.74. Bath & Body Works has a current ratio of 1.38 and a quick ratio of 0.67, with a beta of 1.387, indicating moderate volatility.

Analysts Set New Price Targets

On May 28, 2026, Telsey Advisory Group maintained a "hold" rating with a price target of $22. TD Cowen, on the same date, reiterated its "buy" rating with a $25 target. Barclays and Goldman Sachs both maintained "hold" ratings with targets of $23. Overall, the consensus recommendation is "hold," with an average target price of $25.57.

About Bath & Body Works

Bath & Body Works, Inc. operates as a specialty retailer focusing on personal care and home fragrance products. The company, headquartered in Columbus, Ohio, offers a variety of products including body lotions, hand soaps, and home fragrance diffusers. With operations in the United States and Canada, Bath & Body Works also partners internationally through franchise and licensing arrangements. The company, led by CEO Daniel Heaf, employs about 9,071 people.

Bottom Line

Lucy Brady's recent share purchase adds to a series of insider transactions at Bath & Body Works, suggesting confidence in the company's prospects. The stock, currently trading at $19.40, reflects a diverse range of institutional activity. Analysts maintain varied ratings, with a consensus "hold" and price targets between $19 and $54. Investors will continue to watch Bath & Body Works as it navigates the retail landscape.